Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 10 studies | 26% ± 9% | |
astrocyte | 8 studies | 30% ± 14% | |
glutamatergic neuron | 7 studies | 44% ± 27% | |
fibroblast | 7 studies | 24% ± 8% | |
GABAergic neuron | 7 studies | 39% ± 23% | |
interneuron | 6 studies | 37% ± 24% | |
oligodendrocyte precursor cell | 5 studies | 30% ± 10% | |
oligodendrocyte | 5 studies | 26% ± 9% | |
macrophage | 4 studies | 24% ± 4% | |
microglial cell | 4 studies | 23% ± 4% | |
neuron | 4 studies | 27% ± 9% | |
epithelial cell | 4 studies | 28% ± 8% | |
GABAergic interneuron | 3 studies | 21% ± 6% | |
granule cell | 3 studies | 20% ± 2% | |
abnormal cell | 3 studies | 19% ± 3% | |
endothelial cell of lymphatic vessel | 3 studies | 21% ± 5% | |
pericyte | 3 studies | 22% ± 5% | |
adipocyte | 3 studies | 21% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 8 studies | 37% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3573.66 | 1445 / 1445 | 100% | 24.17 | 183 / 183 |
lung | 100% | 4525.90 | 578 / 578 | 100% | 30.61 | 1155 / 1155 |
stomach | 100% | 3048.15 | 359 / 359 | 100% | 24.04 | 286 / 286 |
breast | 100% | 4855.45 | 459 / 459 | 100% | 31.48 | 1116 / 1118 |
prostate | 100% | 3950.48 | 245 / 245 | 100% | 30.79 | 501 / 502 |
uterus | 100% | 6617.15 | 170 / 170 | 100% | 30.29 | 458 / 459 |
pancreas | 100% | 2351.14 | 327 / 328 | 100% | 25.64 | 178 / 178 |
bladder | 100% | 4410.33 | 21 / 21 | 100% | 26.80 | 502 / 504 |
ovary | 100% | 5079.34 | 180 / 180 | 100% | 18.77 | 428 / 430 |
thymus | 100% | 4038.42 | 653 / 653 | 100% | 24.11 | 602 / 605 |
kidney | 100% | 3052.11 | 89 / 89 | 99% | 24.97 | 894 / 901 |
skin | 100% | 6162.34 | 1809 / 1809 | 99% | 34.20 | 468 / 472 |
intestine | 100% | 4062.76 | 966 / 966 | 99% | 26.08 | 522 / 527 |
brain | 98% | 1902.62 | 2588 / 2642 | 100% | 25.12 | 705 / 705 |
adrenal gland | 100% | 3467.45 | 258 / 258 | 97% | 18.15 | 224 / 230 |
liver | 98% | 1873.08 | 222 / 226 | 98% | 13.38 | 397 / 406 |
adipose | 100% | 4979.02 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5343.98 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 20.21 | 80 / 80 |
spleen | 100% | 2981.59 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 24.51 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.23 | 1 / 1 |
heart | 99% | 2685.24 | 855 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 1444.80 | 788 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 10.49 | 28 / 29 |
peripheral blood | 69% | 1004.57 | 642 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042044 | Biological process | fluid transport |
GO_0015014 | Biological process | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process |
GO_0030210 | Biological process | heparin biosynthetic process |
GO_0008217 | Biological process | regulation of blood pressure |
GO_0055078 | Biological process | sodium ion homeostasis |
GO_0002062 | Biological process | chondrocyte differentiation |
GO_0015012 | Biological process | heparan sulfate proteoglycan biosynthetic process |
GO_0000271 | Biological process | polysaccharide biosynthetic process |
GO_0051923 | Biological process | sulfation |
GO_0050891 | Biological process | multicellular organismal-level water homeostasis |
GO_0060350 | Biological process | endochondral bone morphogenesis |
GO_0001707 | Biological process | mesoderm formation |
GO_0060047 | Biological process | heart contraction |
GO_0006024 | Biological process | glycosaminoglycan biosynthetic process |
GO_0010467 | Biological process | gene expression |
GO_0001503 | Biological process | ossification |
GO_0006487 | Biological process | protein N-linked glycosylation |
GO_0042311 | Biological process | vasodilation |
GO_0044344 | Biological process | cellular response to fibroblast growth factor stimulus |
GO_1902494 | Cellular component | catalytic complex |
GO_0016020 | Cellular component | membrane |
GO_0043541 | Cellular component | UDP-N-acetylglucosamine transferase complex |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0015020 | Molecular function | glucuronosyltransferase activity |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0050508 | Molecular function | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity |
GO_0050509 | Molecular function | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity |
GO_0042328 | Molecular function | heparan sulfate N-acetylglucosaminyltransferase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0008375 | Molecular function | acetylglucosaminyltransferase activity |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0016757 | Molecular function | glycosyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | EXT2 |
Protein name | Exostosin-2 (EC 2.4.1.224) (Exostosin glycosyltransferase 2) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Heparan sulfate co-polymerase subunit EXT1) (Multiple exostoses protein 2) Exostoses (Multiple) 2 Exostosin glycosyltransferase 2 |
Synonyms | |
Description | FUNCTION: Glycosyltransferase forming with EXT1 the heterodimeric heparan sulfate polymerase which catalyzes the elongation of the heparan sulfate glycan backbone . Glycan backbone extension consists in the alternating transfer of (1->4)-beta-D-GlcA and (1->4)-alpha-D-GlcNAc residues from their respective UDP-sugar donors. Both EXT1 and EXT2 are required for the full activity of the polymerase since EXT1 bears the N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity within the complex while EXT2 carries the glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity . Heparan sulfate proteoglycans are ubiquitous components of the extracellular matrix and play an important role in tissue homeostasis and signaling . . |
Accessions | ENST00000343631.4 [Q93063-1] ENST00000358681.8 [Q93063-2] ENST00000683870.1 A0A804HJW9 Q6NUL1 ENST00000684124.1 ENST00000684039.1 A0A804HL74 ENST00000682993.1 [Q93063-1] Q93063 A0A804HLF7 ENST00000533608.7 [Q93063-1] ENST00000682359.1 A0A804HIU8 A0A804HHX4 ENST00000682815.1 ENST00000683000.1 [Q93063-1] A0A804HKG2 ENST00000395673.8 [Q93063-1] ENST00000684533.1 A0A804HKG8 ENST00000682711.1 |